Comment from Guttmacher Institute

Summary: The Guttmacher Institute, a research and policy organization, supports the citizen petition to eliminate the Risk Evaluation and Mitigation Strategy (REMS) program for mifepristone. They argue that the medication is safe and effective, and that removing REMS requirements will improve access to medication abortion, particularly for patients in rural or underserved areas.